TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nordic Bioscience A/S
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
31,720
|
42,167
|
36,445 |
Earnings before taxes |
5,771
|
18,572
|
17,144 |
Total assets |
39,066
|
36,559
|
35,757 |
Current assets |
27,421
|
25,195
|
25,305 |
Current liabilities |
25,020
|
20,851
|
13,716 |
Equity capital |
8,265
|
9,637
|
15,832 |
- share capital |
1,342
|
1,345
![]() |
1,345 |
Employees (average) |
150
![]() |
150
![]() |
150 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
21.2%
|
26.4%
|
44.3% |
Turnover per employee |
211
|
281
|
243 |
Profit as a percentage of turnover |
18.2%
|
44.0%
|
47.0% |
Return on assets (ROA) | |||
Current ratio |
109.6%
|
120.8%
|
184.5% |
Return on equity (ROE) |
69.8%
|
192.7%
|
108.3% |
Change turnover |
-10,353
|
5,723
|
36,445 |
Change turnover % |
-25%
|
16% | |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.